Controlled and Regulated Chemicals: Ensuring Compliance in Research and Manufacturing

White Paper Feb 16, 2021

Any industry that handles large amounts of chemicals needs to be able to correctly identify and handle both controlled and regulated substances. Pharmaceutical industries face demanding regulatory requirements relating to the safe and legal use, storage and supply of chemicals. As companies and regulatory complexity continue to grow, simply name searching or using key words to check chemical libraries for the applicable regulations will not suffice. However, compliance checking via the chemical structure can be exploited to easily and automatically find out if a chemical is regulated or controlled.

Download this whitepaper to:

• Discover how to determine what chemicals are regulated or controlled

• Explore common challenges and simple steps that can be taken to improve compliance

• Decipher how regulatory requirements differ between countries

VIEW WHITE PAPER

Related White Papers

Affinity Analysis for Accelerated Screening and Characterization of Lead Molecules

White Paper

One of the common molecular analyses is the determination of a lead molecule’s binding kinetics and affinity to the target. This warrants the need for analytical instruments capable of characterizing such molecules. Download this whitepaper to discover an approach that accurately measures multiple high-affinity interactions over long run times.

AI-Powered Analytics Transforms LIMS Data Into Valuable, Action-Ready Insights

White Paper

Data accessibility has been a challenge because the lab operator’s relationship to data is usually prescribed by preset LIMS features. Using data science algorithms, it is now possible to process and integrate all LIMS and enterprise data to provide valuable insights and timely, meaningful recommendations. Access this whitepaper to discover a technology that provides a holistic view of your data, delivers statistical and business analysis and increases productivity.

Join the mRNA Vaccine Race With Affinity Purification

White Paper

mRNA based interventions are becoming much more prevalent in current times, with several leading SARS-CoV-2 vaccines relying on mRNA technology. Access this whitepaper to learn about an affinity-based method that can streamline mRNA vaccine production and be used for biotherapeutic development.

Like what you just read? You can find similar content on the communities below.

Biopharma Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free